Cannell & Co’s Idexx Laboratories IDXX Stock Holding History

Cannell & Co’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$222K	Buy	+400	New	+$188K	0.01%	249
2023 Q3	–	Sell	-400	Closed	-$201K	–	265
2023 Q2	$201K	Hold	400	–	–	0.01%	248
2023 Q1	$200K	Buy	+400	New	+$191K	0.01%	252
2022 Q2	–	Sell	-466	Closed	-$255K	–	277
2022 Q1	$255K	Hold	466	–	–	0.01%	255
2021 Q4	$307K	Hold	466	–	–	0.01%	252
2021 Q3	$290K	Hold	466	–	–	0.01%	256
2021 Q2	$294K	Hold	466	–	–	0.01%	253
2021 Q1	$228K	Hold	466	–	–	0.01%	260
2020 Q4	$233K	Buy	+466	New	+$209K	0.01%	253

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cannell & Co's IDXX Position: Q4 2023 in Review

Cannell & Co opened a new position in Idexx Laboratories (IDXX) in Q4 2023: 400 shares worth $222K. The stake represents 0.01% of the portfolio and ranks #249 among its holdings. This is a return to the name: Cannell & Co previously reported a position in IDXX as recently as Q2 2023.

Cannell & Co first reported a position in IDXX in Q4 2020 and has held it in 9 quarters since. The position peaked at $307K in Q4 2021. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

Cannell & Co held 400 shares of Idexx Laboratories worth $222K as of Q4 2023.
Idexx Laboratories was a new Cannell & Co position in Q4 2023.
Idexx Laboratories made up 0.01% of Cannell & Co's portfolio in Q4 2023, its #249 holding.
Cannell & Co first reported a position in Idexx Laboratories in Q4 2020 and has held it in 9 quarters since.
Cannell & Co's Idexx Laboratories position peaked at $307K in Q4 2021.
1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.